We are live on
!
Find out more
RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.8B
1-Year Est. Return
36.16%
This Fund
S&P 500
This Quarter
Est. Return
-8.89%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.51B
AUM Growth
-$307M
(-11%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
0.6%
Top 10 Holdings %
Top 10 Hldgs %
23.56%
Holding
327
New
15
Increased
111
Reduced
164
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Digital Turbine
APPS
|
+$22.2M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$11.6M |
| 3 |
Iovance Biotherapeutics
IOVA
|
+$7.01M |
| 4 |
CHUY
Chuy's Holdings, Inc. Common Stock
CHUY
|
+$6.39M |
| 5 |
Mativ Holdings
MATV
|
+$5.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MIME
Mimecast Limited
MIME
|
+$15.9M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$12.6M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$11.1M |
| 4 |
NPTN
NEOPHOTONICS CORP
NPTN
|
+$6.5M |
| 5 |
Collegium Pharmaceutical
COLL
|
+$5.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Healthcare | 23.72% |
| 3 | Industrials | 14.58% |
| 4 | Consumer Discretionary | 12.89% |
| 5 | Communication Services | 6.15% |
Similar funds
GC
BP
CIM
JCM
KPM
BFG
ST
MCC
Rice Hall James & Associates's Q1 2022 Portfolio in Review
As of Q1 2022, Rice Hall James & Associates held 327 positions worth $2.51B, down 11% from $2.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rice Hall James & Associates's Q1 2022 filing shows 15 new, 111 increased, 164 reduced and 21 closed positions. Its largest new stake was Digital Turbine: 491,443 shares worth $21.5M. The largest sale was Mimecast Limited, an estimated $15.9M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.
- Rice Hall James & Associates's largest Q1 2022 buy was Digital Turbine: 491,443 shares worth $21.5M.
- Rice Hall James & Associates added most to Neurocrine Biosciences in Q1 2022, an estimated $11.6M increase.
- Rice Hall James & Associates's biggest Q1 2022 reduction was Mimecast Limited, cutting an estimated $15.9M.
- Rice Hall James & Associates fully exited Zogenix, Inc. in Q1 2022, selling an estimated $12.6M.
- Rice Hall James & Associates's ten largest holdings make up 24% of its $2.51B portfolio in Q1 2022.
- Rice Hall James & Associates opened 15 new positions and closed 21 in Q1 2022.
- Rice Hall James & Associates's portfolio value fell 11% quarter-over-quarter to $2.51B.
Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.